Search Results

There are 28952 results for: content related to: Treatment of relapsed idiopathic thrombocytopenic purpura with the anti-CD20 monoclonal antibody rituximab: a pilot study

  1. Symptomatic Epstein–Barr virus reactivation in a patient with acute myeloid leukaemia and treatment with the monoclonal anti-CD20 antibody rituximab

    European Journal of Haematology

    Volume 69, Issue 1, July 2002, Pages: 50–53, Christoph Tinchon, Holger W. Auner, Christine Beham-Schmid, Stephan W. Aberle, Heinz Sill and Werner Linkesch

    Article first published online : 19 SEP 2002, DOI: 10.1034/j.1600-0609.2002.02740.x

  2. Favorable outcome of primary cutaneous marginal zone lymphoma treated with intralesional rituximab

    European Journal of Haematology

    Volume 77, Issue 4, October 2006, Pages: 300–303, Maria-Christina Kyrtsonis, Marina P. Siakantaris, Christina Kalpadakis, Maria N. Dimopoulou, Theodoros P. Vassilakopoulos, Flora N. Kontopidou, Christina Antoniou, Penelope Korkolopoulou, Panayiotis Panayiotidis and Gerassimos A. Pangalis

    Article first published online : 19 JUL 2006, DOI: 10.1111/j.1600-0609.2006.00720.x

  3. Stable remission after administration of rituximab in a patient with primary hepatic marginal zone B-cell lymphoma

    European Journal of Haematology

    Volume 74, Issue 5, May 2005, Pages: 445–447, H. R. Gockel, J. Heidemann, A. Lugering, R. M. Mesters, R. Parwaresch, W. Domschke and N. Lugering

    Article first published online : 5 APR 2005, DOI: 10.1111/j.1600-0609.2005.00419.x

  4. The therapeutic use of rituximab in non-Hodgkin's lymphoma

    European Journal of Haematology

    Volume 78, Issue s67, January 2007, Pages: 5–14, Robert Marcus and Anton Hagenbeek

    Article first published online : 7 DEC 2006, DOI: 10.1111/j.1600-0579.2004.00340.x-i1

  5. Rituximab to treat chronic lymphoproliferative disorder-associated pure red cell aplasia

    European Journal of Haematology

    Volume 82, Issue 3, March 2009, Pages: 235–239, Giovanni D’Arena, Maria Luigia Vigliotti, Matteo Dell’Olio, Maria Rosaria Villa, Saverio Mantuano, Potito Rosario Scalzulli, Antonio La Sala, Antonio Abbadessa, Lucia Mastrullo and Nicola Cascavilla

    Article first published online : 20 NOV 2008, DOI: 10.1111/j.1600-0609.2008.01187.x

  6. Rituximab for warm-type idiopathic autoimmune hemolytic anemia: a retrospective study of 11 adult patients

    European Journal of Haematology

    Volume 79, Issue 1, July 2007, Pages: 53–58, Giovanni D’Arena, Catello Califano, Mario Annunziata, Alfredo Tartarone, Silvana Capalbo, Oreste Villani, Giovanni Amendola, Giuseppe Pietrantuono, Felicetto Ferrara, Antonio Pinto, Pellegrino Musto, Alfonso Maria D’Arco and Nicola Cascavilla

    Article first published online : 28 MAR 2007, DOI: 10.1111/j.1600-0609.2007.00861.x

  7. Clinical efficacy of immunochemotherapy with fludarabine, epirubicin and rituximab in the treatment for chronic lymphocytic leukaemia and prolymphocytic leukaemia

    European Journal of Haematology

    Volume 87, Issue 5, November 2011, Pages: 426–433, Kai Uwe Chow, Soo-Zin Kim, Nils von Neuhoff, Brigitte Schlegelberger, Stephan Stilgenbauer, Lydia Wunderle, Hans-Joerg Cordes and Lothar Bergmann

    Article first published online : 23 AUG 2011, DOI: 10.1111/j.1600-0609.2011.01680.x

  8. Anti-CD20 monoclonal antibody therapy in relapsed MALT lymphoma of the conjunctiva

    European Journal of Haematology

    Volume 73, Issue 4, October 2004, Pages: 258–262, Holger Nückel, Daniel Meller, Klaus-Peter Steuhl and Ulrich Dührsen

    Article first published online : 3 SEP 2004, DOI: 10.1111/j.1600-0609.2004.00299.x

  9. Severe idiopathic erythroblastic synartesis: successful treatment with the anti-CD20 monoclonal antibody rituximab

    European Journal of Haematology

    Volume 84, Issue 6, June 2010, Pages: 547–549, Georgios Papakonstantinou, Helmut Loeffler, Torsten Haferlach and Wolfram Brugger

    Article first published online : 22 JAN 2010, DOI: 10.1111/j.1600-0609.2010.01420.x

  10. Low-dose rituximab in adult patients with primary immune thrombocytopenia

    European Journal of Haematology

    Volume 85, Issue 4, October 2010, Pages: 329–334, Francesco Zaja, Nicola Vianelli, Stefano Volpetti, Marta Lisa Battista, Marzia Defina, Salvatore Palmieri, Monica Bocchia, Marta Medeot, Stefano De Luca, Felicetto Ferrara, Miriam Isola, Michele Baccarani and Renato Fanin

    Article first published online : 10 JUN 2010, DOI: 10.1111/j.1600-0609.2010.01486.x

  11. Rituximab (anti-CD20 monoclonal antibody) as consolidation of first-line CHOP chemotherapy in patients with follicular lymphoma: a phase II study

    European Journal of Haematology

    Volume 69, Issue 1, July 2002, Pages: 21–26, Gerald Jäeger, Peter Neumeister, Ruth Brezinschek, Gerald Höfler, Franz Quehenberger, Werner Linkesch and Heinz Sill

    Article first published online : 19 SEP 2002, DOI: 10.1034/j.1600-0609.2002.01692.x

  12. Standard-dose anti-CD20 antibody rituximab has efficacy in chronic lymphocytic leukaemia: results from a Nordic multicentre study

    European Journal of Haematology

    Volume 69, Issue 3, September 2002, Pages: 129–134, M. Itälä, CH. Geisler, E. Kimby, E. Juvonen, G. Tjonnfjord, K. Karlsson and K. Remes

    Article first published online : 25 OCT 2002, DOI: 10.1034/j.1600-0609.2002.02786.x

  13. Long-term remission in HIV-negative patients with multicentric Castleman's disease using rituximab

    European Journal of Haematology

    Volume 76, Issue 2, February 2006, Pages: 119–123, Makoto Ide, Yasunori Kawachi, Yoichiro Izumi, Kanji Kasagi and Tetsuro Ogino

    Article first published online : 22 DEC 2005, DOI: 10.1111/j.1600-0609.2005.00570.x

  14. Significant thrombocytopenia associated with the addition of rituximab to a combination of fludarabine and cyclophosphamide in the treatment of relapsed follicular lymphoma

    European Journal of Haematology

    Volume 73, Issue 4, October 2004, Pages: 251–257, Eugen Leo, Lars Scheuer, Ingo G. H. Schmidt-Wolf, Mohammed Kerowgan, Christina Schmitt, Albrecht Leo, Tanja Baumbach, Alwin Kraemer, Ulrich Mey, Axel Benner, Reza Parwaresch and Anthony D. Ho

    Article first published online : 3 SEP 2004, DOI: 10.1111/j.1600-0609.2004.00293.x

  15. Large-cell transformation of chronic lymphocytic leukemia and follicular lymphoma during or soon after treatment with fludarabine–rituximab-containing regimens: natural history- or therapy-related complication?

    European Journal of Haematology

    Volume 68, Issue 2, February 2002, Pages: 80–83, Yossi Cohen, Nael Da'as, Diana Libster, Gail Amir, Alan Berrebi and Aaron Polliack

    Article first published online : 29 APR 2002, DOI: 10.1034/j.1600-0609.2002.01599.x

  16. Refractory thrombotic thrombocytopenic purpura in a 16-year-old girl: successful treatment with bortezomib

    European Journal of Haematology

    Volume 92, Issue 1, January 2014, Pages: 80–82, Tessa van Balen, Michiel F. Schreuder, Huib de Jong and Nicole C. A. J. van de Kar

    Article first published online : 24 OCT 2013, DOI: 10.1111/ejh.12206

  17. CD20-positive plasmablastic lymphoma with excellent response to bortezomib combined with rituximab

    European Journal of Haematology

    Volume 93, Issue 1, July 2014, Pages: 77–80, Min Yan, Zhaoming Dong, Frank Zhao, Thomas Chauncey, Delva Deauna-Limayo, Jessica Wang-Rodriguez, Dayu Liu, Huan-You Wang and Renate Pilz

    Article first published online : 1 APR 2014, DOI: 10.1111/ejh.12286

  18. Prevalence of pneumococcal vaccination in adult immune thrombocytopenia patients exposed to rituximab or to splenectomy

    European Journal of Haematology

    Volume 90, Issue 5, May 2013, Pages: 438–439, Guillaume Moulis, Laurent Sailler, Agnès Sommet, Maryse Lapeyre-Mestre and Daniel Adoue

    Article first published online : 14 MAR 2013, DOI: 10.1111/ejh.12091

  19. Cladribine combined with rituximab (R-2-CdA) therapy is an effective salvage therapy in relapsed or refractory indolent B-cell non-Hodgkin lymphoma

    European Journal of Haematology

    Volume 86, Issue 2, February 2011, Pages: 117–123, Hirokazu Nagai, Michinori Ogura, Shigeru Kusumoto, Naoto Takahashi, Motoko Yamaguchi, Nobuyuki Takayama, Tomohiro Kinoshita, Toshiko Motoji, Kazuma Ohyashiki, Hiroshi Kosugi, Shin Matsuda, Kazunori Ohnishi, Ken Omachi and Tomomitsu Hotta

    Article first published online : 29 DEC 2010, DOI: 10.1111/j.1600-0609.2010.01552.x

  20. You have free access to this content
    Maintenance Rituximab is associated with improved clinical outcome in rituximab naïve patients with Waldenstrom Macroglobulinaemia who respond to a rituximab-containing regimen

    British Journal of Haematology

    Volume 154, Issue 3, August 2011, Pages: 357–362, Steven P. Treon, Christina Hanzis, Robert J. Manning, Leukothea Ioakimidis, Christopher J. Patterson, Zachary R. Hunter, Patricia Sheehy and Barry Turnbull

    Article first published online : 25 MAY 2011, DOI: 10.1111/j.1365-2141.2011.08750.x